Evozyne, NVIDIA develop AI model for producing new synthetic proteins

By NS Healthcare Staff Writer

13 Jan 23

The new model is intended for the design of new therapeutic targets for untreatable diseases and is expected…

PharmaceuticalsBiotechnology Equipment and Materials

Moderna to acquire Japan’s Oriciro Genomics for $85m

By NS Healthcare Staff Writer

05 Jan 23

The acquisition is expected to support Moderna’s suite of platform technologies, and OriCiro’s synthetic biology and enzyme technologies…

PharmaceuticalsBiotechnology Equipment and Materials

Astellas Pharma to acquire 15% stake in Taysha Gene Therapies

By NS Healthcare Staff Writer

26 Oct 22

Taysha Gene Therapies is engaged in developing gene therapies for the treatment of Rett syndrome and giant axonal…

PharmaceuticalsBiotechnology Equipment and Materials

Kite gets FDA nod to begin commercial production at new RVV facility

By NS Healthcare Staff Writer

04 Oct 22

Viral vectors are said to be very important components required for manufacturing Kite’s cell therapies for the treatment…

PharmaceuticalsBiotechnology Equipment and Materials

Food Forest Abundance Announces New Way to Grow Food for Entire Communities

By NS Healthcare Staff Writer

14 Sep 22

"The solution we demonstrate is not hypothetical, the solution has been proven all over the world, and it…

PharmaceuticalsBiotechnology Equipment and Materials

MilliporeSigma to invest €130m to boost manufacturing capabilities in France

By NS Healthcare Staff Writer

09 Sep 22

The company, which is the life science business of Merck, will use the investment to further ramp up…

PharmaceuticalsBiotechnology Equipment and Materials

Synaffix licenses ADC technologies to Emergence in deal worth up to $360m

By NS Healthcare Staff Writer

07 Sep 22

Emergence Therapeutics has secured license to use the GlycoConnect, HydraSpace and exatecan-based SYNtecan E linker-payload technologies to develop…

Partnerships and Licensing AgreementsPharmaceuticals

Evonik to build $220m new lipid production facility for mRNA-based therapies in US

By NS Healthcare Staff Writer

03 Jun 22

Evonik is planning to commence the construction in early 2023, which will create more than 80 highly skilled…

PharmaceuticalsBiotechnology Equipment and Materials

Fujifilm to acquire recombinant proteins manufacturer Shenandoah

By NS Healthcare Staff Writer

23 Mar 22

Shenandoah’s portfolio of recombinant proteins is expected to complement Fujifilm Irvine Scientific’s advanced cell culture solutions and expertise…

PharmaceuticalsBiotechnology Equipment and Materials

Biotechnology firm Altos Labs launches with $3bn funding

By NS Healthcare Staff Writer

20 Jan 22

Altos team contain scientists, clinicians, and leaders from both academia and industry, jointly working on reversing disease, injury,…

PharmaceuticalsBiotechnology Equipment and Materials